St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Fanconi anemia is a rare and serious blood disorder. It is a type of bone marrow failure. Bone marrow makes blood cells. In Fanconi anemia, the bone marrow does not make enough blood cells or stops making them.
Fanconi anemia can also affect many of the body’s tissues and organs. Children with this disease have a higher risk of having other serious health conditions, including problems with the bones (especially thumbs), kidneys, or heart. Fanconi anemia can also lead to leukemia, a cancer of the blood.
Fanconi anemia is an inherited disorder. This means it is passed down through families. Children who have Fanconi anemia have a higher risk for birth defects.
Fanconi anemia is not the same as Fanconi syndrome. Fanconi syndrome affects the kidneys.
Fanconi anemia usually appears before age 12. Early signs and symptoms may include:
About 60% (6 in 10) of children with Fanconi anemia are born with at least one of the following:
Your child’s health care provider will do a medical exam and ask about your family health history. They will do several types of tests.
Tests may include a complete blood count, a bone marrow test, and imaging such as MRI and ultrasound.
Treating Fanconi anemia can include both short-term and long-term treatment strategies:
There is no known cure for Fanconi anemia. But treatment advances have improved survival rates. About 80% (8 in 10) people live to 18 years or older.
About 10% (1 in 10) of people with Fanconi anemia have leukemia during childhood. They are more likely to have cancerous solid tumors as adults. The risk increases as people get older.
Women who have Fanconi anemia are at a higher risk for tumors in their reproductive organs than women without Fanconi anemia.
St. Jude provides the highest quality of care for patients with Fanconi anemia:
St. Jude offers comprehensive surveillance and standard-of-care treatment in consultation with other providers who have expertise in Fanconi anemia.
Study goal:
The main goal of this trial is to collect DNA from individuals with non-cancerous blood diseases and their family members. Researchers will use the DNA to study how genes cause and influence these diseases. All research data will be confidential.
Diagnosis:
Non-malignant blood diseases (non-therapeutic)
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334